why choose us

First received: September 27, 2024

Clinical Trial: A Study to Learn How Safe BAY3018250 is, How it Moves Into, Through and Out of the Body, and How it Affects the Body in Healthy Chinese Participants

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Acute Venous and Arterial Thrombotic and Thromboembolic Events

Study Type: INTERVENTIONAL


Official Title: A Randomized, Single-blind, Placebo-controlled, Single Dose Escalation Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BAY 3018250 in Chinese Healthy Participants

Brief Summary: Researchers are looking for a better way to treat people who have acute venous and arterial thrombotic and thromboembolic events.Acute venous and arterial thrombotic and thromboembolic events refer to blood clots that form and cause blockages in blood vessels that may cause serious complications.The study treatment BAY3018250 is under development to treat acute venous and arterial thrombotic and thromboembolic events.It works by dissolving blood clots.In this study, participants will be healthy and will not…

Read more